International Registry of Hereditary Calcium Stone Disease/ Primary Hyperoxaluria Study - Full Text View

International Registry of Hereditary Calcium Stone Disease/ Primary Hyperoxaluria Study (PH)

This study is currently recruiting participants.
Verified by University of California, Davis, February 2008

Sponsors and Collaborators:	University of California, Davis National Institutes of Health (NIH)
Information provided by:	University of California, Davis
ClinicalTrials.gov Identifier:	NCT00616525

Purpose

The purpose of this study is to accumulate data about rare genetic diseases affecting the kidney.

Condition

Primary Hyperoxaluria

Genetics Home Reference related topics:

primary hyperoxaluria

ChemIDplus related topics:

Calcium gluconate

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort, Prospective

Official Title:	International Registry of Hereditary Calcium Stone Disease/ Primary Hyperoxaluria Study

Further study details as provided by University of California, Davis:

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	10
Study Start Date:	May 2006
Estimated Study Completion Date:	January 2010
Estimated Primary Completion Date:	January 2010 (Final data collection date for primary outcome measure)

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

pediatric nephrology outpatient clinic at UCDMC

Criteria

Inclusion Criteria:

Primary Hyperoxaluria

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00616525

Contacts


Contact: J. Gularte	(916) 734-7222

Locations


United States, California
	UC Davis Medical Center	Recruiting
	Sacramento, California, United States, 95817

Sponsors and Collaborators

University of California, Davis

National Institutes of Health (NIH)

Investigators


Principal Investigator:	Lavjay Butani, M.D.	University of California, Davis

More Information

Related Info This link exits the ClinicalTrials.gov site

Responsible Party:	UC Davis Medical Center ( Lavjay Butani, M.D./ Associate Professor & Section Chief of Pediatric Nephrology )
Study ID Numbers:	200614392-2
First Received:	February 4, 2008
Last Updated:	February 14, 2008
ClinicalTrials.gov Identifier:	NCT00616525
Health Authority:	United States: Institutional Review Board

Keywords provided by University of California, Davis:

Primary Hyperoxaluria

Study placed in the following topic categories:

Metabolism, Inborn Errors

Hyperoxaluria, Primary

Hyperoxaluria

Kidney Diseases

Metabolic disorder

Calculi

Oxalosis

Additional relevant MeSH terms:

Metabolic Diseases

Genetic Diseases, Inborn

Urologic Diseases

Carbohydrate Metabolism, Inborn Errors

ClinicalTrials.gov processed this record on July 03, 2008